CS
MR

Candriam SCA’s MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A MR Stock Holding History

Candriam SCA’s Portfolio MR Stock Details MR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-10,000
Closed -$274K – 683
2015
Q1 		$274K Sell
10,000
-55,000
-85% -$1.51M 0.01% 594
2014
Q4 		$1.72M Buy
+65,000
New +$1.9M 0.04% 376

Other funds holding MR

Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.69B AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
GAM
Genesis Asset Managers Guernsey, Channel Islands, United Kingdom $3.53B AUM 1.54% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
CCMH
Cornerstone Capital Management Holdings New York $14.3B AUM 33.3% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Candriam SCA's MR Position: Q2 2015 in Review

Candriam SCA sold out of MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A (MR) in Q2 2015, closing a stake of 10,000 shares — an estimated $274K sold.

Candriam SCA first reported a position in MR in Q4 2014 and held it in 2 quarters. The position peaked at $1.72M in Q4 2014. 118 funds tracked by Wall St. Rank hold MR as of Q2 2015.

  • Candriam SCA reported no remaining MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position as of Q2 2015 after selling out during the quarter.
  • Candriam SCA sold 10,000 MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A shares in Q2 2015, an estimated $274K.
  • Candriam SCA first reported a position in MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A in Q4 2014 and held it in 2 quarters.
  • Candriam SCA's MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position peaked at $1.72M in Q4 2014.
  • 118 funds tracked by Wall St. Rank held MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A as of Q2 2015.

Based on Candriam SCA's 13F filing for Q2 2015, filed 29 Jul 2015.